BioNexus Gene Lab Corp. logo

BioNexus Gene Lab Corp.

BGLC | NASDAQ
Chart Builder DCF Calculator
$1.46
-$0.04 (-2.67%)
At close: Sep 22, 2026, 4:00 PM ET
$1.45
-$0.01 (-0.68%)
After-hours: Sep 22, 2026, 7:30 PM ET

Company Profile

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Key Executives

Name Position
Su-Leng Tan Chief Executive Officer, President, Secretary & Director
Set Fui Chong Chief Financial Officer
Kwan Wah Chan Marketing Manager
Too Kam Tham Managing Director

Latest SEC Filings

Date Type Title
Jul 31, 2026 3 Filing
Jul 31, 2026 3 Filing
Jul 31, 2026 3 Filing
Jul 31, 2026 3 Filing
Jul 31, 2026 3 Filing
Jul 28, 2026 8-K Current Report
Jun 05, 2026 8-K Current Report
May 15, 2026 10-Q Quarterly Report
Apr 14, 2026 10-K Annual Report
Mar 31, 2026 NT 10-K Filing
View All SEC Filings
BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. logo
Country Malaysia
IPO Date Jan 7, 2021
Industry Industrial - Distribution
Sector Industrials
Employees 19
CEO Su-Leng Tan

Contact Details

Tower B, Vertical Business Suite Kuala Lumpur, WP 59200 Malaysia

Stock Details

Ticker Symbol BGLC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001737523
CUSIP Number 090628306
ISIN Number US0906283066
SIC Code 8071

© 2026 bestshares.com. All rights reserved.